Candidate gene analysis using imputed genotypes: Cell cycle single-nucleotide polymorphisms and ovarian cancer risk

Cancer Epidemiology Biomarkers and Prevention

Volumn 18, Issue 3, 2009, Pages 935-944

  Goode, Ellen L ^a   Fridley, Brooke L ^a   Vierkant, Robert A ^a   Cunningham, Julie M ^a   Phelan, Catherine M ^b   Anderson, Stephanie ^a   Rider, David N ^a   White, Kristin L ^a   Pankratz, V Shane ^a   Song, Honglin ^c   Hogdall, Estrid ^d   Kjaer, Susanne K ^d   Whittemore, Alice S ^e   DiCioccio, Richard ^f   Ramus, Susan J ^g   Gayther, Simon A ^g   Schildkraut, Joellen M ^h   Pharaoh, Paul P D ^c   Sellers, Thomas A ^b  

^a Mayo Clinic   (United States)

^b H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^e STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f ROSWELL PARK CANCER INSTITUTE   (United States)

^g UNIVERSITY COLLEGE LONDON   (United Kingdom)

^h DUKE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYCLIN DEPENDENT KINASE INHIBITOR 2A; CYCLIN DEPENDENT KINASE INHIBITOR 2B; CYCLIN DEPENDENT KINASE INHIBITOR 2C; CYCLIN DEPENDENT KINASE INHIBITOR 2D; CCND1 PROTEIN, HUMAN; CCNE1 PROTEIN, HUMAN; CDK2 PROTEIN, HUMAN; CDKN2B PROTEIN, HUMAN; CYCLIN D1; CYCLIN E; ONCOPROTEIN;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER RISK; CELL CYCLE; CONTROLLED STUDY; DISEASE ASSOCIATION; EPITHELIUM; FEMALE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; OVARY CANCER; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; ALLELE; CASE CONTROL STUDY; GENETICS; MIDDLE AGED; OVARY TUMOR; PROBABILITY; REGISTER; RISK; STATISTICAL MODEL; UNITED STATES;

ADULT; AGED; ALLELES; CASE-CONTROL STUDIES; CELL CYCLE; CYCLIN D1; CYCLIN E; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASE INHIBITOR P15; CYCLIN-DEPENDENT KINASE INHIBITOR P16; FEMALE; GENOTYPE; HUMANS; LOGISTIC MODELS; MARKOV CHAINS; MIDDLE AGED; MINNESOTA; NEOPLASM INVASIVENESS; NORTH CAROLINA; ONCOGENE PROTEINS; OVARIAN NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; REGISTRIES; RISK;

EID: 64549144262     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-08-0860     Document Type: Article

References (47)

1. Nam EJ, Kim YT. Alteration of cell-cycle regulation in epithelial ovarian cancer. Int J Gynecol Cancer 2008;18:1169-1182
2. Rakoff-Nahoum S. Why cancer and inflammation? Yale J Biol Med 2006;79:123-130
3. Cooper GM, Hausman RE. The cell: a molecular approach. Sunderlander: Sinauer Associates, Inc.; 2007.
4. Sherr CJ, Roberts JM. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 1999;13:1501-1512 (Pubitemid 29297917)
5. Pharoah PD, Tyrer J, Dunning AM, Easton DF, Ponder BA. Association between common variation in 120 candidate genes and breast cancer risk. PLoS Genet 2007;3:e42. (Pubitemid 46535758)
6. Driver KE, Song H, Lesueur F, et al. Association of single-nucleotide polymorphisms in the cell cycle genes with breast cancer in the British population. Carcinogenesis 2008;29:333-341
7. Chang BL, Zheng SL, Isaacs SD, et al. A polymorphism in the CDKN1B gene is associated with increased risk of hereditary prostate cancer. Cancer Res 2004;64:1997-1999 (Pubitemid 38339445)
8. Hosgood HD III, Menashe I, Shen M, et al. Pathway-based evaluation of 380 candidate genes and lung cancer susceptibility suggests the importance of the cell cycle pathway. Carcinogenesis 2008;29:1938-1943
9. Ye Y, Yang H, Grossman HB, Dinney C, Wu X, Gu J. Genetic variants in cell cycle control pathway confer susceptibility to bladder cancer. Cancer 2008;112:2467-2474
10. Wu X, Gu J, Grossman HB, et al. Bladder cancer predisposition: a multigenic approach to DNA-repair and cell-cycle-control genes. Am J Hum Genet 2006;78:464-479 (Pubitemid 43291228)
11. Huang M, Spitz MR, Gu J, et al. Cyclin D1 gene polymorphism as a risk factor for oral premalignant lesions. Carcinogenesis 2006;27:2034-2037 (Pubitemid 44530578)
12. Hazra A, Chanock S, Giovannucci E, et al. Large-scale evaluation of genetic variants in candidate genes for colorectal cancer risk in the Nurses' Health Study and the Health Professionals' Follow-up Study. Cancer Epidemiol Biomarkers Prev 2008;17:311-319
13. Milde-Langosch K, Ocon E, Becker G, Loning T. p16/MTS1 inactivation in ovarian carcinomas: high frequency of reduced protein expression associated with hyper-methylation or mutation in endometrioid and mucinous tumors. Int J Cancer 1998;79:61-65 (Pubitemid 28157728)
14. Kudoh K, Ichikawa Y, Yoshida S, et al. Inactivation of p16/CDKN2 and p15/MTS2 is associated with prognosis and response to chemotherapy in ovarian cancer. Int J Cancer 2002;99:579-582 (Pubitemid 34461612)
15. Schildkraut JM, Moorman PG, Bland AE, et al. Cyclin E overexpression in epithelial ovarian cancer characterizes an etiologic subgroup. Cancer Epidemiol Biomarkers Prev 2008;17:585-593
16. Li SB, Schwartz PE, Lee WH, Yang-Feng TL. Allele loss at the retinoblastoma locus in human ovarian cancer. J Natl Cancer Inst 1991;83:637-640
17. Gayther SA, Song H, Ramus SJ, et al. Tagging single nucleotide polymorphisms in cell cycle control genes and susceptibility to invasive epithelial ovarian cancer. Cancer Res 2007;67:3027-3035 (Pubitemid 46724839)
18. Ramus SJ, Vierkant RA, Johnatty SE, et al. Consortium analysis of 7 candidate SNPs for ovarian cancer. Int J Cancer 2008;123:380-388
19. Goode EL, Fridley BL, Sun Z, et al. Comparison of tagging single-nucleotide polymorphism methods in association analyses. BMC Proc 2007;1 Suppl 1:S6-.
20. Sun YV, Kardia SL. Imputing missing genotypic data of single-nucleotide polymorphisms using neural networks. Eur J Hum Genet 2008;16:487-495
21. Foulkes AS, Yucel R, Reilly MP. Mixed modeling and multiple imputation for unobservable genotype clusters. Stat Med 2008;27:2784-2801
22. Servin B, Stephens M. Imputation-based analysis of association studies: candidate regions and quantitative traits. PLoS Genet 2007;3:e114. (Pubitemid 47203979)
23. Roberts A, McMillan L, Wang W, Parker J, Rusyn I, Threadgill D. Inferring missing genotypes in large SNP panels using fast nearest-neighbor searches over sliding windows. Bioinformatics 2007;23:i401-7. (Pubitemid 47244426)
24. Dai JY, Ruczinski I, LeBlanc M, Kooperberg C. Imputation methods to improve inference in SNP association studies. Genet Epidemiol 2006;30:690-702. (Pubitemid 44851516)
25. Marchini J, Howie B, Myers S, McVean G, Donnelly P. A new multipoint method for genome wide association studies by imputation of genotypes. Nat Genet 2007;39:906-913 (Pubitemid 47014502)
26. Yu Z, Schaid DJ. Methods to impute missing genotypes for population data. Hum Genet 2007;122:495-504. (Pubitemid 350148961)
27. Song H, Ramus SJ, Shadforth D, et al. Common variants in RB1 gene and risk of invasive ovarian cancer. Cancer Res 2006;66:10220-10226 (Pubitemid 44672078)
28. Sellers TA, Huang Y, Cunningham J, et al. Association of single nucleotide polymorphisms in glycosylation genes with risk of epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev 2008;17:397-404.
29. Cunningham JM, Sellers TA, Schildkraut JM, et al. Performance of amplified DNA in an Illumina Golden Gate Bead Array assay. Cancer Epidemiol Biomarkers Prev 2008;17:1781-1789
30. Sellers TA, Schildkraut JM, Pankratz VS, et al. Estrogen bioactivation, genetic polymorphisms, and ovarian cancer. Cancer Epidemiol Biomarkers Prev 2005;14:2536-2543 (Pubitemid 41752712)
31. Song H, Ramus SJ, Quaye L, et al. Common variants in mismatch repair genes and risk of invasive ovarian cancer. Carcinogenesis 2006;27:2235-2242 (Pubitemid 44644812)
32. Auranen A, Song H, Waterfall C, et al. Polymorphisms in DNA repair genes and epithelial ovarian cancer risk. Int J Cancer 2005;117:611-618 (Pubitemid 41504549)
33. Carlson CS, Eberle MA, Rieder MJ, Yi Q, Kruglyak L, Nickerson DA. Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. Am J Hum Genet 2004;74:106-120 (Pubitemid 38085242)
34. Frazer KA, Ballinger DG, Cox DR, et al. A second generation human haplotype map of over 3.1 million SNPs. Nature 2007;449:851-861 (Pubitemid 47598626)
35. de Bakker PI, Yelensky R, Pe'er I, Gabriel SB, Daly MJ, Altshuler D. Efficiency and power in genetic association studies. Nat Genet 2005;37:1217-1223
36. Stram DO. Tag SNP selection for association studies. Genet Epidemiol 2004;27:365-374 (Pubitemid 39602320)
37. National Institute of Environmental Health Sciences Environmental Genome Project. Available from: http://egp.gs.washington. Accessed October, 2005.
38. Oliphant A, Barker DL, Stuelpnagel JR, Chee MS. BeadArray technology: enabling an accurate, cost-effective approach to high-throughput genotyping. Biotechniques 2002;Suppl:56-8, 60-61
39. Scheet P, Stephens M. A fast and flexible statistical model for large-scale population genotype data: applications to inferring missing genotypes and haplotypic phase. Am J Hum Genet 2006;78:629-644
40. Little R, Rubin D. Statistical analysis with missing data. New York: Wiley; 2002.
41. Yang HJ, Liu VW, Wang Y, Tsang PC, Ngan HY. Differential DNA methylation profiles in gynecological cancers and correlation with clinico-pathological data. BMC Cancer 2006;6:212. (Pubitemid 44382757)
42. Suh DS, Yoon MS, Choi KU, Kim JY. Significance of E2F-1 overexpression in epithelial ovarian cancer. Int J Gynecol Cancer 2008;18:492-498
43. 1 arrest through suppression of Skp2-2 and CDK4 in SK-OV-3 cells. Int J Oncol 2008;32:435-439
44. Tanner MA, Wong WH. The calculation of posterior distributions by data augmentation. J Am Stat Assoc 1987;82:526-640.
45. Schafer JL. Incomplete multivariate data. Monographs on statistics and applied probability. Boca Raton: Chapman and Hall/CRC; 1997.
46. Hopke PK, Liu C, Rubin DP. Multiple imputation for multivariate data with missing and below-threshold measurements: time-series concentrations of pollutants in the Arctic. Biometrics 2001;57:22-33. (Pubitemid 32200134)
47. Fridley BL, de Andrade M. Missing phenotype data imputation in pedigree data analysis. Genet Epidemiol 2008;32:52-60.